相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nucleolar stress: From development to cancer
M. Carmen Lafita-Navarro et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2023)
RNA-interference screen for p53 regulators unveils a role of WDR75 in ribosome biogenesis
Pavel Moudry et al.
CELL DEATH AND DIFFERENTIATION (2022)
9-Aminoacridine Inhibits Ribosome Biogenesis by Targeting Both Transcription and Processing of Ribosomal RNA
Leonid Anikin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
The small-molecule BMH-21 directly inhibits transcription elongation and DNA occupancy of RNA polymerase I in vivo and in vitro
Ruth Q. Jacobs et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2022)
Genome-wide RNAi screen identifies novel players in human 60S subunit biogenesis including key enzymes of polyamine metabolism
Kerstin Dorner et al.
NUCLEIC ACIDS RESEARCH (2022)
A high-throughput assay for directly monitoring nucleolar rRNA biogenesis
Carson J. Bryant et al.
OPEN BIOLOGY (2022)
Ribosome Biogenesis: A Central Player in Cancer Metastasis and Therapeutic Resistance
Amr R. Elhamamsy et al.
CANCER RESEARCH (2022)
Discovery and Evaluation of Novel Angular Fused Pyridoquinazolinonecarboxamides as RNA Polymerase I Inhibitors
Tony E. Dorado et al.
ACS MEDICINAL CHEMISTRY LETTERS (2022)
CETSA interaction proteomics define specific RNA-modification pathways as key components of fluorouracil-based cancer drug cytotoxicity
Ying Yu Liang et al.
CELL CHEMICAL BIOLOGY (2022)
Anti-Cancer Agents in Medicinal Chemistry
Biswajit Das et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2021)
Recent Updates on Mechanisms of Resistance to 5-Fluorouracil and Reversal Strategies in Colon Cancer Treatment
Shamin Azwar et al.
BIOLOGY-BASEL (2021)
The nucleolus as a multiphase liquid condensate
Denis L. J. Lafontaine et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2021)
In silico methods and tools for drug discovery
Bilal Shaker et al.
COMPUTERS IN BIOLOGY AND MEDICINE (2021)
Cryo-EM structures of human RNA polymerase I
Agata D. Misiaszek et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2021)
The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma
Min Pan et al.
NATURE COMMUNICATIONS (2021)
Structure of the human RNA polymerase I elongation complex
Dan Zhao et al.
CELL DISCOVERY (2021)
Aggregation and Supramolecular Self-Assembly of Low-Energy Red Luminescent Alkynylplatinum(II) Complexes for RNA Detection, Nucleolus Imaging, and RNA Synthesis Inhibitor Screening
Angela Sin-Yee Law et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)
Ubiquitin-mediated DNA damage response is synthetic lethal with G-quadruplex stabilizer CX-5461
Tehmina Masud et al.
SCIENTIFIC REPORTS (2021)
The Ribosomal Gene Loci-The Power behind the Throne
Konstantin I. Panov et al.
GENES (2021)
CX-5461 Enhances the Efficacy of APR-246 via Induction of DNA Damage and Replication Stress in Triple-Negative Breast Cancer
Ashwini Makhale et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Transcription-associated topoisomerase 2α a (TOP2A) activity is a major effector of cytotoxicity induced by G-quadruplex ligands
Madeleine Bossaert et al.
ELIFE (2021)
DNA Intercalators Inhibit Eukaryotic Ribosomal RNA Synthesis by Impairing the Initiation of Transcription
William J. Andrews et al.
GENES (2021)
The exon-junction complex helicase eIF4A3 controls cell fate via coordinated regulation of ribosome biogenesis and translational output
Dimitris C. Kanellis et al.
SCIENCE ADVANCES (2021)
Quinacrine Induces Nucleolar Stress in Treatment-Refractory Ovarian Cancer Cell Lines
Derek B. Oien et al.
CANCERS (2021)
Targeting ribosomal G-quadruplexes with naphthalene-diimides as RNA polymerase I inhibitors for colorectal cancer treatment
Victoria Sanchez-Martin et al.
CELL CHEMICAL BIOLOGY (2021)
Early nucleolar responses differentiate mechanisms of cell death induced by oxaliplatin and cisplatin
Emily C. Sutton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Targeting RNA with small molecules: from fundamental principles towards the clinic
James P. Falese et al.
CHEMICAL SOCIETY REVIEWS (2021)
Dysregulated Ribosome Biogenesis Reveals Therapeutic Liabilities in Cancer
Sladana Bursac et al.
TRENDS IN CANCER (2021)
The RNA polymerase I transcription inhibitor CX-5461 cooperates with topoisomerase 1 inhibition by enhancing the DNA damage response in homologous recombination-proficient high-grade serous ovarian cancer
Shunfei Yan et al.
BRITISH JOURNAL OF CANCER (2021)
The antimalarial drug amodiaquine stabilizes p53 through ribosome biogenesis stress, independently of its autophagy-inhibitory activity
Jaime A. Espinoza et al.
CELL DEATH AND DIFFERENTIATION (2020)
5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future
Sona Vodenkova et al.
PHARMACOLOGY & THERAPEUTICS (2020)
CETSA in integrated proteomics studies of cellular processes
Nayana Prabhu et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2020)
Cancer-associated mutations in the ribosomal protein L5 gene dysregulate the HDM2/p53-mediated ribosome biogenesis checkpoint
Ines Orsolic et al.
ONCOGENE (2020)
The primary mechanism of cytotoxicity of the chemotherapeutic agent CX-5461 is topoisomerase II poisoning
Peter M. Bruno et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Replication and ribosomal stress induced by targeting pyrimidine synthesis and cellular checkpoints suppress p53-deficient tumors
Sona Hubackova et al.
CELL DEATH & DISEASE (2020)
Targeting the RNA Polymerase I Transcription for Cancer Therapy Comes of Age
Rita Ferreira et al.
CELLS (2020)
Targeting the Human 80S Ribosome in Cancer: From Structure to Function and Drug Design for Innovative Adjuvant Therapeutic Strategies
Arnaud Gilles et al.
CELLS (2020)
CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancer
Elaine Sanij et al.
NATURE COMMUNICATIONS (2020)
Actinomycin D downregulates Sox2 and improves survival in preclinical models of recurrent glioblastoma
Jessica T. Taylor et al.
NEURO-ONCOLOGY (2020)
Triptolide interrupts rRNA synthesis and induces the RPL23-MDM2-p53 pathway to repress lung cancer cells
Juan Wang et al.
ONCOLOGY REPORTS (2020)
Nucleotide depletion reveals the impaired ribosome biogenesis checkpoint as a barrier against DNA damage
Joffrey Pelletier et al.
EMBO JOURNAL (2020)
rDNA Chromatin Activity Status as a Biomarker of Sensitivity to the RNA Polymerase I Transcription Inhibitor CX-5461
Jinbae Son et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Nucleolar RNA polymerase II drives ribosome biogenesis
Karan J. Abraham et al.
NATURE (2020)
Transcriptional suppression of ribosomal DNA with phase separation
Satoru Ide et al.
SCIENCE ADVANCES (2020)
Inhibition of the de novo pyrimidine biosynthesis pathway limits ribosomal RNA transcription causing nucleolar stress in glioblastoma cells
M. Carmen Lafita-Navarro et al.
PLOS GENETICS (2020)
Sempervirine inhibits RNA polymerase I transcription independently from p53 in tumor cells
Cinzia Caggiano et al.
CELL DEATH DISCOVERY (2020)
Translational Control in Cancer
Nathaniel Robichaud et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2019)
Ribosomal Proteins Control Tumor Suppressor Pathways in Response to Nucleolar Stress
Frederic Lessard et al.
BIOESSAYS (2019)
Down-regulation of MYCN protein by CX-5461 leads to neuroblastoma tumor growth suppression
Jordan S. Taylor et al.
JOURNAL OF PEDIATRIC SURGERY (2019)
Inhibition of RNA polymerase III transcription by Triptolide attenuates colorectal tumorigenesis
Xia Liang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Phase-to-Phase With Nucleoli - Stress Responses, Protein Aggregation and Novel Roles of RNA
Leena Latonen
FRONTIERS IN CELLULAR NEUROSCIENCE (2019)
Ribosome biogenesis during cell cycle arrest fuels EMT in development and disease
Varsha Prakash et al.
NATURE COMMUNICATIONS (2019)
First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation Study
Amit Khot et al.
CANCER DISCOVERY (2019)
Discovery of novel inhibitors of ribosome biogenesis by innovative high throughput screening strategies
Catherine E. Scull et al.
BIOCHEMICAL JOURNAL (2019)
The nucleolus: a central response hub for the stressors that drive cancer progression
Shannon E. Weeks et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
Targeting RNA Polymerase I with Hernandonine Inhibits Ribosomal RNA Synthesis and Tumor Cell Growth
Yen-Ting Chen et al.
MOLECULAR CANCER RESEARCH (2019)
IMP dehydrogenase-2 drives aberrant nucleolar activity and promotes tumorigenesis in glioblastoma
Satoshi Kofuji et al.
NATURE CELL BIOLOGY (2019)
Effective targeting of RNA polymerase I in treatment-resistant prostate cancer
Jin-Yih Low et al.
PROSTATE (2019)
The Targeting of RNA Polymerase I Transcription Using CX-5461 in Combination with Radiation Enhances Tumour Cell Killing Effects in Human Solid Cancers
Mohammed Ismael et al.
CANCERS (2019)
Therapeutic Approaches Targeting Nucleolus in Cancer
Pietro Carotenuto et al.
CELLS (2019)
The Nucleolus: A Multiphase Condensate Balancing Ribosome Synthesis and Translational Capacity in Health, Aging and Ribosomopathies
Carl C. Correll et al.
CELLS (2019)
Nucleolar Stress Induction by Oxaliplatin and Derivatives
Emily C. Sutton et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
Ribosome biogenesis: An emerging druggable pathway for cancer therapeutics
Frederic Catez et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma
Oyvind H. Hald et al.
ONCOGENE (2019)
CX-5461 Inhibits Pancreatic Ductal Adenocarcinoma Cell Growth, Migration and Induces DNA Damage
Btissame El Hassouni et al.
MOLECULES (2019)
ProTargetMiner as a proteome signature library of anticancer molecules for functional discovery
Amir Ata Saei et al.
NATURE COMMUNICATIONS (2019)
A cell-based screening system for RNA polymerase I inhibitors
Xiao Tan et al.
MEDCHEMCOMM (2019)
Small molecule activators of the p53 response
Marcus J. G. W. Ladds et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2019)
c-MYC G-quadruplex binding by the RNA polymerase I inhibitor BMH-21 and analogues revealed by a combined NMR and biochemical Approach
Loana Musso et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2018)
Ribosome biogenesis and cancer: basic and translational challenges
Xose R. Bustelo et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2018)
Treating hematological malignancies with drugs inhibiting ribosome biogenesis: when and why
Enrico Derenzini et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Senescence-associated ribosome biogenesis defects contributes to cell cycle arrest through the Rb pathway
Frederic Lessard et al.
NATURE CELL BIOLOGY (2018)
Principles for targeting RNA with drug-like small molecules
Katherine Deigan Warner et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Nucleolus as an emerging hub in maintenance of genome stability and cancer pathogenesis
Mikael S. Lindstrom et al.
ONCOGENE (2018)
Metarrestin, a perinucleolar compartment inhibitor, effectively suppresses metastasis
Kevin J. Frankowski et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
The Amaryllidaceae Alkaloid Haemanthamine Binds the Eukaryotic Ribosome to Repress Cancer Cell Growth
Simone Pellegrino et al.
STRUCTURE (2018)
A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
Marcus J. G. W. Ladds et al.
NATURE COMMUNICATIONS (2018)
Diverse Regulators of Human Ribosome Biogenesis Discovered by Changes in Nucleolar Number
Katherine I. Farley-Barnes et al.
CELL REPORTS (2018)
Small-Molecule Targeting of RNA Polymerase I Activates a Conserved Transcription Elongation Checkpoint
Ting Wei et al.
CELL REPORTS (2018)
Use of the iNo score to discriminate normal from altered nucleolar morphology, with applications in basic cell biology and potential in human disease diagnostics
Vassiliki Stamatopoulou et al.
NATURE PROTOCOLS (2018)
Targeting mutant p53 for efficient cancer therapy
Vladimir J. N. Bykov et al.
NATURE REVIEWS CANCER (2018)
Perturbation of RNA Polymerase I transcription machinery by ablation of HEATR1 triggers the RPL5/RPL11-MDM2-p53 ribosome biogenesis stress checkpoint pathway in human cells
Zsofia Turi et al.
CELL CYCLE (2018)
RAM-589.555 a new Polymerase-1 inhibitor as innovative targeted-treatment for multiple sclerosis
A. Achiron et al.
JOURNAL OF NEUROIMMUNOLOGY (2017)
Novel Assay to Detect RNA Polymerase I Activity In Vivo
Gunes Guner et al.
MOLECULAR CANCER RESEARCH (2017)
Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4
Zdenek Skrott et al.
NATURE (2017)
A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress
Peter M. Bruno et al.
NATURE MEDICINE (2017)
CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumours
Hong Xu et al.
NATURE COMMUNICATIONS (2017)
The ribosomal protein gene RPL5 is a haploinsufficient tumor suppressor in multiple cancer types
Laura Fancello et al.
ONCOTARGET (2017)
Translational reprogramming of colorectal cancer cells induced by 5-fluorouracil through a miRNA-dependent mechanism
Zeina Bash-Imam et al.
ONCOTARGET (2017)
A dataset of images and morphological profiles of 30 000 small-molecule treatments using the Cell Painting assay
Mark-Anthony Bray et al.
GIGASCIENCE (2017)
Actinomycin D Down-regulates SOX2 Expression and Induces Death in Breast Cancer Stem Cells
Tuhin Das et al.
ANTICANCER RESEARCH (2017)
RNA Polymerase I Inhibition with CX-5461 as a Novel Therapeutic Strategy to Target MYC in Multiple Myeloma
Hans C. Lee et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Direct relationship between the level of p53 stabilization induced by rRNA synthesis-inhibiting drugs and the cell ribosome biogenesis rate
F. Scala et al.
ONCOGENE (2016)
Combination Therapy Targeting Ribosome Biogenesis and mRNA Translation Synergistically Extends Survival in MYC-Driven Lymphoma
Jennifer R. Devlin et al.
CANCER DISCOVERY (2016)
The Roles of MDM2 and MDMX in Cancer
Orit Karni-Schmidt et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 11 (2016)
Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone
Roberto Marques Damiani et al.
ARCHIVES OF TOXICOLOGY (2016)
Commentary on Participation of p53 Protein in the Cellular Response to DNA Damage
Michael B. Kastan
CANCER RESEARCH (2016)
Potent, Reversible, and Specific Chemical Inhibitors of Eukaryotic Ribosome Biogenesis
Shigehiro A. Kawashima et al.
CELL (2016)
Coexisting Liquid Phases Underlie Nucleolar Subcompartments
Marina Feric et al.
CELL (2016)
The Dual Inhibition of RNA Pol I Transcription and PIM Kinase as a New Therapeutic Approach to Treat Advanced Prostate Cancer
Richard J. Rebello et al.
CLINICAL CANCER RESEARCH (2016)
The stress-inducible transcription factor ATF4 accumulates at specific rRNA-processing nucleolar regions after proteasome inhibition
Valentina Galimberti et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2016)
Homoharringtonine, aclarubicin and cytarabine (HAA) regimen as the first course of induction therapy is highly effective for acute myeloid leukemia with t (8;21)
Hong-Hu Zhu et al.
LEUKEMIA RESEARCH (2016)
Investigating actinomycin D binding to G-quadruplex, i-motif and double-stranded DNA in 27-nt segment of c-MYC gene promoter
Zhila Niknezhad et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2016)
Cell Painting, a high-content image-based assay for morphological profiling using multiplexed fluorescent dyes
Mark-Anthony Bray et al.
NATURE PROTOCOLS (2016)
Involvement of human ribosomal proteins in nucleolar structure and p53-dependent nucleolar stress
Emilien Nicolas et al.
NATURE COMMUNICATIONS (2016)
CETSA screening identifies known and novel thymidylate synthase inhibitors and slow intracellular activation of 5-fluorouracil
Helena Almqvist et al.
NATURE COMMUNICATIONS (2016)
Inhibition of RNA polymerase I transcription initiation by CX-5461 activates non-canonical ATM/ATR signaling
Jaclyn Quin et al.
ONCOTARGET (2016)
Alu element-containing RNAs maintain nucleolar structure and function
Maiwen Caudron-Herger et al.
EMBO JOURNAL (2015)
Azide vs Alkyne Functionalization in Pt(II) Complexes for Post-treatment Click Modification: Solid-State Structure, Fluorescent Labeling, and Cellular Fate
Regina Wirth et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia
A. Eriksson et al.
BLOOD CANCER JOURNAL (2015)
Targeted cancer therapy with ribosome biogenesis inhibitors: a real possibility?
Elisa Brighenti et al.
ONCOTARGET (2015)
Depletion of the cisplatin targeted HMGB-box factor UBF selectively induces p53-independent apoptotic death in transformed cells
Nourdine Hamdane et al.
ONCOTARGET (2015)
rRNA synthesis inhibitor, CX-5461, activates ATM/ATR pathway in acute lymphoblastic leukemia, arrests cells in G2 phase and induces apoptosis
Sandeep S. Negi et al.
ONCOTARGET (2015)
Genome-wide RNAi Screening Identifies Protein Modules Required for 40S Subunit Synthesis in Human Cells
Lukas Badertscher et al.
CELL REPORTS (2015)
Activation of the tumor suppressor p53 upon impairment of ribosome biogenesis
Sladana Bursac et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Targeting the nucleolus for cancer intervention
Jaclyn E. Quin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
A Targeting Modality for Destruction of RNA Polymerase I that Possesses Anticancer Activity
Karita Peltonen et al.
CANCER CELL (2014)
Non-genotoxic activation of p53 through the RPL11-dependent ribosomal stress pathway
Lucia Morgado-Palacin et al.
CARCINOGENESIS (2014)
Targeting the nucleolus for cancer-specific activation of p53
Denis Drygin et al.
DRUG DISCOVERY TODAY (2014)
p53 and ribosome biogenesis stress: The essentials
Lior Golomb et al.
FEBS LETTERS (2014)
The Drug Diazaborine Blocks Ribosome Biogenesis by Inhibiting the AAA-ATPase Drg1
Mathias Loibl et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Selective Inhibition of rDNA Transcription by a Small-Molecule Peptide That Targets the Interface between RNA Polymerase I and Rrn3
Katrina Rothblum et al.
MOLECULAR CANCER RESEARCH (2014)
Small Molecule BMH-Compounds That Inhibit RNA Polymerase I and Cause Nucleolar Stress
Karita Peltonen et al.
MOLECULAR CANCER THERAPEUTICS (2014)
DNA intercalator BMH-21 inhibits RNA polymerase I independent of DNA damage response
Laureen Colis et al.
ONCOTARGET (2014)
The antimalarial amodiaquine causes autophagic-lysosomal and proliferative blockade sensitizing human melanoma cells to starvation- and chemotherapy-induced cell death
Shuxi Qiao et al.
AUTOPHAGY (2013)
Functional ribosome biogenesis is a prerequisite for p53 destabilization: impact of chemotherapy on nucleolar functions and RNA metabolism
Kaspar Burger et al.
BIOLOGICAL CHEMISTRY (2013)
The Cell's Nucleolus: an Emerging Target for Chemotherapeutic Intervention
Amanda J. Pickard et al.
CHEMMEDCHEM (2013)
Cyclin-dependent Kinase 9 Links RNA Polymerase II Transcription to Processing of Ribosomal RNA
Kaspar Burger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Old Drug, New Target ELLIPTICINES SELECTIVELY INHIBIT RNA POLYMERASE I TRANSCRIPTION
William J. Andrews et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Eukaryotic ribosome biogenesis at a glance
Emma Thomson et al.
JOURNAL OF CELL SCIENCE (2013)
The Complexity of Human Ribosome Biogenesis Revealed by Systematic Nucleolar Screening of Pre-rRNA Processing Factors
Lionel Tafforeau et al.
MOLECULAR CELL (2013)
Topoisomerase IIα promotes activation of RNA polymerase I transcription by facilitating pre-initiation complex formation
Swagat Ray et al.
NATURE COMMUNICATIONS (2013)
Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin
Baoxu Pang et al.
NATURE COMMUNICATIONS (2013)
5S Ribosomal RNA Is an Essential Component of a Nascent Ribosomal Precursor Complex that Regulates the Hdm2-p53 Checkpoint
Giulio Donati et al.
CELL REPORTS (2013)
The 5S RNP Couples p53 Homeostasis to Ribosome Biogenesis and Nucleolar Stress
Katherine E. Sloan et al.
CELL REPORTS (2013)
Dysregulation of the basal RNA polymerase transcription apparatus in cancer
Megan J. Bywater et al.
NATURE REVIEWS CANCER (2013)
Roles of the mammalian target of rapamycin, mTOR, in controlling ribosome biogenesis and protein synthesis
Valentina Iadevaia et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
Natural Product Triptolide Mediates Cancer Cell Death by Triggering CDK7-Dependent Degradation of RNA Polymerase II
Stefano Giustino Manzo et al.
CANCER RESEARCH (2012)
Discovery of CX-5461, the First Direct and Selective Inhibitor of RNA Polymerase I, for Cancer Therapeutics
Mustapha Haddach et al.
ACS MEDICINAL CHEMISTRY LETTERS (2012)
p53 -Dependent and -Independent Nucleolar Stress Responses
Karl Holmberg Olausson et al.
Cells (2012)
Targeting RNA Polymerase I with an Oral Small Molecule CX-5461 Inhibits Ribosomal RNA Synthesis and Solid Tumor Growth
Denis Drygin et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Beyond DNA binding - a review of the potential mechanisms mediating quinacrine's therapeutic activities in parasitic infections, inflammation, and cancers
Reza Ehsanian et al.
CELL COMMUNICATION AND SIGNALING (2011)
Selective inhibition of rRNA transcription downregulates E2F-1: a new p53-independent mechanism linking cell growth to cell proliferation
Giulio Donati et al.
JOURNAL OF CELL SCIENCE (2011)
Nucleolar disruption and apoptosis are distinct neuronal responses to etoposide-induced DNA damage
Maciej Pietrzak et al.
JOURNAL OF NEUROCHEMISTRY (2011)
XPB, a subunit of TFIIH, is a target of the natural product triptolide
Denis V. Titov et al.
NATURE CHEMICAL BIOLOGY (2011)
Proteasome inhibitors induce nucleolar aggregation of proteasome target proteins and polyadenylated RNA by altering ubiquitin availability
L. Latonen et al.
ONCOGENE (2011)
Triptolide (TPL) Inhibits Global Transcription by Inducing Proteasome-Dependent Degradation of RNA Polymerase II (Pol II)
Ying Wang et al.
PLOS ONE (2011)
The Role of p53 in Ribosomopathies
Stefano Fumagalli et al.
SEMINARS IN HEMATOLOGY (2011)
The RNA Polymerase I Transcription Machinery: An Emerging Target for the Treatment of Cancer
Denis Drygin et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)
An ARF-Independent c-MYC-Activated Tumor Suppression Pathway Mediated by Ribosomal Protein-Mdm2 Interaction
Everardo Macias et al.
CANCER CELL (2010)
Mitomycin C Inhibits Ribosomal RNA A NOVEL CYTOTOXIC MECHANISM FOR BIOREDUCTIVE DRUGS
Ryan G. Snodgrass et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Chemotherapeutic Drugs Inhibit Ribosome Biogenesis at Various Levels
Kaspar Burger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Identification of Novel p53 Pathway Activating Small-Molecule Compounds Reveals Unexpected Similarities with Known Therapeutic Agents
Karita Peltonen et al.
PLOS ONE (2010)
Transcriptional Regulation by p53
Rachel Beckerman et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
MYC in Oncogenesis and as a Target for Cancer Therapies
Ami Albihn et al.
ADVANCES IN CANCER RESEARCH, VOL 107 (2010)
MYC as a regulator of ribosome biogenesis and protein synthesis
Jan van Riggelen et al.
NATURE REVIEWS CANCER (2010)
High prevalence of retinoblastoma protein loss in triple-negative breast cancers and its association with a good prognosis in patients treated with adjuvant chemotherapy
D. Trere et al.
ANNALS OF ONCOLOGY (2009)
Novel Molecular Mechanism for Actinomycin D Activity as an Oncogenic Promoter G-Quadruplex Binder
Hyun-Jin Kang et al.
BIOCHEMISTRY (2009)
Interactions of Actinomycin D with Human Telomeric G-Quadruplex DNA
Jason S. Hudson et al.
BIOCHEMISTRY (2009)
The Role of Myc-Induced Protein Synthesis in Cancer
Davide Ruggero
CANCER RESEARCH (2009)
Anticancer Activity of CX-3543: A Direct Inhibitor of rRNA Biogenesis
Denis Drygin et al.
CANCER RESEARCH (2009)
The DNA-damage response in human biology and disease
Stephen P. Jackson et al.
NATURE (2009)
Absence of nucleolar disruption after impairment of 40s ribosome biogenesis reveals an rpL11-translation-dependent mechanism of p53 induction
Stefano Fumagalli et al.
NATURE CELL BIOLOGY (2009)
Nucleolus, ribosomes, and cancer
Lorenzo Montanaro et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Loss of retinoblastoma tumor suppressor protein makes human breast cancer cells more sensitive to antimetabolite exposure
Massimo Derenzini et al.
CLINICAL CANCER RESEARCH (2008)
Mycophenolic acid activation of p53 requires ribosomal proteins l5 and l11
Xiao-Xin Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Different effects of ribosome biogenesis inhibition on cell proliferation in retinoblastoma protein- and p53-deficient and proficient human osteosarcoma cell lines
L. Montanaro et al.
CELL PROLIFERATION (2007)
Cellular response to etoposide treatment
Alessandra Montecucco et al.
CANCER LETTERS (2007)
The multifunctional nucleolus
Francois-Michel Boisvert et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
5-fluorouracil activation of p53 involves an MDM2-ribosomal protein interaction
Xiao-Xin Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Putting a finger on growth surveillance -: Insight into MDM2 zinc finger-ribosomal protein interactions
Mikael S. Lindstrom et al.
CELL CYCLE (2007)
Ribosome biogenesis and cell growth: mTOR coordinates transcription by all three classes of nuclear RNA polymerases
C. Mayer et al.
ONCOGENE (2006)
Acridine derivatives activate p53 and induce tumor cell death through Bax
WG Wang et al.
CANCER BIOLOGY & THERAPY (2005)
Transcriptional blockade induces p53-dependent apoptosis associated with translocation of p53 to mitochondria
Y Arima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Formation of nucleoplasmic protein aggregates impairs nuclear function in response to SiO2 nanoparticles
M Chen et al.
EXPERIMENTAL CELL RESEARCH (2005)
Actinomycin D induces histone γ-H2AX foci and complex formation of γ-H2AX with Ku70 and nuclear DNA helicase II
HE Mischo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I
C Grandori et al.
NATURE CELL BIOLOGY (2005)
c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription
A Arabi et al.
NATURE CELL BIOLOGY (2005)
Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5
MS Dai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses
CP Rubbi et al.
EMBO JOURNAL (2003)
Regulation of HDM2 activity by the ribosomal protein L11
MAE Lohrum et al.
CANCER CELL (2003)
Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway
YP Zhang et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
High-throughput measurement of the Tp53 response to anticancer drugs and random compounds using a stably integrated Tp53-responsive luciferase reporter
TA Sohn et al.
CARCINOGENESIS (2002)
Cyclin-dependent kinases govern formation and maintenance of the nucleolus
V Sirri et al.
JOURNAL OF CELL BIOLOGY (2002)
Nucleolar damage correlates with neurotoxicity induced by different platinum drugs
MJ McKeage et al.
BRITISH JOURNAL OF CANCER (2001)
Common and reversible regulation of wild-type p53 function and of ribosomal biogenesis by protein kinases in human cells
T David-Pfeuty et al.
ONCOGENE (2001)
Evidence of p53-dependent cross-talk between ribosome biogenesis and the cell cycle:: Effects of nucleolar protein bop1 on G1/S transition
DG Pestov et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis
K Boon et al.
EMBO JOURNAL (2001)
Genotoxicity of streptonigrin:: a review
AD Bolzán et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2001)
Proliferation, but not growth, blocked by conditional deletion of 40S ribosomal protein S6
S Volarevic et al.
SCIENCE (2000)
分享论文
